| Serial Number | 88588324 |
| Word Mark | AIM IMMUNOTECH |
| Filing Date | Thursday, August 22, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 23, 2024 |
| Registration Number | 7458330 |
| Registration Date | Tuesday, July 23, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 31, 2019 |
| Goods and Services | Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant, all of the foregoing primarily available by prescription |
| Pseudo Mark | AIM IMMUNOLOGICAL TECH |
| Goods and Services | Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 6, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, June 7, 2023 |
| First Use In Commerce Date | Wednesday, June 7, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 6, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | Saturday, August 31, 2019 |
| First Use In Commerce Date | Saturday, August 31, 2019 |
| Party Name | AIM IMMUNOTECH INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | OCALA, FL 34473 |
| Party Name | AIM IMMUNOTECH INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | OCALA, FL 34473 |
| Party Name | AIM IMMUNOTECH INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | OCALA, FL 34473 |
| Party Name | HEMISPHERX BIOPHARMA, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Orlando, FL 32801 |
| Event Date | Event Description |
| Friday, September 6, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 26, 2019 | NEW APPLICATION ENTERED |
| Wednesday, October 9, 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, November 22, 2019 | ASSIGNED TO EXAMINER |
| Monday, November 25, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 11, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 31, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 31, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, January 9, 2020 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Monday, June 29, 2020 | OPPOSITION INSTITUTED NO. 999999 |
| Thursday, July 23, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, July 20, 2021 | OPPOSITION TERMINATED NO. 999999 |
| Tuesday, July 20, 2021 | OPPOSITION DISMISSED NO. 999999 |
| Tuesday, July 20, 2021 | TTAB RELEASE CASE TO TRADEMARKS |
| Tuesday, August 31, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, February 28, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 28, 2022 | SOU EXTENSION 1 FILED |
| Monday, February 28, 2022 | SOU EXTENSION 1 GRANTED |
| Wednesday, March 2, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, August 31, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, August 31, 2022 | SOU EXTENSION 2 FILED |
| Wednesday, August 31, 2022 | SOU EXTENSION 2 GRANTED |
| Friday, September 2, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, February 28, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 28, 2023 | SOU EXTENSION 3 FILED |
| Tuesday, February 28, 2023 | SOU EXTENSION 3 GRANTED |
| Thursday, March 2, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 23, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Friday, June 23, 2023 | USE AMENDMENT FILED |
| Wednesday, July 19, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, July 19, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, August 9, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 9, 2023 | SU - NON-FINAL ACTION - WRITTEN |
| Wednesday, August 9, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, November 9, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, November 9, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, February 9, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, February 9, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 18, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 18, 2024 | ASSIGNED TO LIE |
| Thursday, June 20, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, July 23, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 23, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Thursday, June 20, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |